Total Payments
$11,874
2024 Payments
$1,667
Companies
41
Transactions
313
Medicare Patients
8,188
Medicare Billing
$761,986
Payment Breakdown by Category
Food & Beverage$8,505 (71.6%)
Travel$3,354 (28.3%)
Education$13.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,505 | 300 | 71.6% |
| Travel and Lodging | $3,354 | 12 | 28.3% |
| Education | $13.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,949 | 27 | $0 (2024) |
| Abbott Laboratories | $2,003 | 15 | $0 (2024) |
| Amgen Inc. | $775.93 | 37 | $0 (2024) |
| ABIOMED | $652.69 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $589.95 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $526.07 | 24 | $0 (2024) |
| Philips Electronics North America Corporation | $487.63 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $427.53 | 22 | $0 (2021) |
| Medtronic, Inc. | $353.20 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $335.06 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,667 | 62 | ABIOMED ($276.10) |
| 2023 | $1,633 | 53 | Medtronic, Inc. ($327.50) |
| 2022 | $1,142 | 40 | BIOTRONIK INC. ($156.90) |
| 2021 | $265.44 | 6 | ABIOMED ($132.56) |
| 2020 | $1,329 | 21 | Boston Scientific Corporation ($1,053) |
| 2019 | $2,135 | 34 | Boston Scientific Corporation ($1,485) |
| 2018 | $1,212 | 38 | Philips Electronics North America Corporation ($458.15) |
| 2017 | $2,490 | 59 | Abbott Laboratories ($1,628) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Heart Failure | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: CARDIOLOGY | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $51.19 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: CARDIOLOGY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Not Applicable | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Cardiology | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $128.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology | ||||||
| 07/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,485 | 3,111 | $972,387 | $225,873 |
| 2022 | 23 | 2,515 | 3,243 | $967,883 | $234,310 |
| 2021 | 26 | 1,870 | 2,408 | $778,096 | $187,484 |
| 2020 | 24 | 1,318 | 1,628 | $515,819 | $114,320 |
Total Patients
8,188
Total Services
10,390
Medicare Billing
$761,986
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 434 | 627 | $202,521 | $53,052 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 208 | 210 | $154,140 | $27,296 | 17.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 66 | 66 | $82,434 | $21,621 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 174 | 174 | $87,000 | $19,769 | 22.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 285 | $67,830 | $17,180 | 25.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 65 | 260 | $17,160 | $11,643 | 67.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 21 | 24 | $45,024 | $10,113 | 22.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 94 | $42,770 | $9,243 | 21.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 51 | $38,913 | $8,979 | 23.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 159 | 159 | $26,076 | $7,934 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 101 | $22,018 | $6,531 | 29.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 46 | 46 | $36,294 | $6,114 | 16.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 31 | 31 | $24,211 | $5,126 | 21.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 78 | 78 | $23,244 | $3,700 | 15.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 66 | 67 | $17,688 | $3,415 | 19.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 321 | 327 | $21,255 | $3,184 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $14,500 | $2,745 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 29 | $9,367 | $2,111 | 22.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 246 | 281 | $7,868 | $1,688 | 21.5% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 20 | 22 | $5,390 | $1,184 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $5,200 | $948.31 | 18.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 23 | 23 | $5,543 | $885.73 | 16.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 71 | $9,301 | $672.37 | 7.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 24 | 24 | $5,328 | $426.24 | 8.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $1,312 | $309.76 | 23.6% |
About Dr. John Lee, MD
Dr. John Lee, MD is a Cardiovascular Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679764948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lee, MD has received a total of $11,874 in payments from pharmaceutical and medical device companies, with $1,667 received in 2024. These payments were reported across 313 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,505).
As a Medicare-enrolled provider, Lee has provided services to 8,188 Medicare beneficiaries, totaling 10,390 services with total Medicare billing of $761,986. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine, Interventional Cardiology
- Location Plano, TX
- Active Since 08/05/2007
- Last Updated 09/09/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1679764948
Products in Payments
- Omnilink Elite vascular stent system (Device) $1,544
- JETSTREAM (Device) $1,123
- GENERAL - VASCULAR ACCESS (Device) $1,022
- Impella (Device) $652.69
- Repatha (Biological) $652.38
- IVUS Systems (Device) $426.26
- ENTRESTO (Drug) $413.60
- XARELTO (Drug) $335.06
- ELIQUIS (Drug) $321.32
- BRILINTA (Drug) $245.81
- Lexiscan (Drug) $235.31
- ELUVIA (Device) $221.68
- LINQ II (Device) $220.84
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $220.31
- LifeVest (Device) $216.07
- VERQUVO (Drug) $211.19
- LEXISCAN (Drug) $192.22
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $179.20
- LEQVIO (Drug) $176.35
- Arcalyst (Drug) $172.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plano
Srinivasa Potluri, Md, MD
Cardiovascular Disease — Payments: $783,265
Cardiovascular Disease $783,265
Dr. David Brown, M.d, M.D
Cardiovascular Disease — Payments: $256,750
Cardiovascular Disease $256,750
David Rawitscher, Md, MD
Cardiovascular Disease — Payments: $244,805
Cardiovascular Disease $244,805
Sahil Bakshi, Do, DO
Cardiovascular Disease — Payments: $193,440
Cardiovascular Disease $193,440
Mordecai Klein, Md, MD
Cardiovascular Disease — Payments: $162,433
Cardiovascular Disease $162,433
Dr. Vijay Ramanath, M.d, M.D
Cardiovascular Disease — Payments: $123,142
Cardiovascular Disease $123,142